The Current Ratio as of November 2024 (TTM) for NeuroMetrix, Inc. (NURO) is 11.62

According to NeuroMetrix, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.62. This represents a change of -16.64% compared to the average of 13.94 of the last 4 quarters.

NeuroMetrix, Inc. (NURO) Historical Current Ratio (quarterly & annually)

How has NURO Current Ratio performed in the past?

The mean historical Current Ratio of NeuroMetrix, Inc. over the last ten years is 7.60. The current 11.62 Current Ratio has changed 15.18% with respect to the historical average. Over the past ten years (40 quarters), NURO's Current Ratio was at its highest in in the December 2022 quarter at 21.79. The Current Ratio was at its lowest in in the December 2019 quarter at 1.58.

NeuroMetrix, Inc. (NURO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroMetrix, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroMetrix, Inc. (NURO) Average Current Ratio

How has NURO Current Ratio performed in the past?

The current Current Ratio of NeuroMetrix, Inc. (NURO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

NeuroMetrix, Inc. (NURO) Current Ratio vs. Peers

How is NURO’s Current Ratio compared to its peers?

NeuroMetrix, Inc.’s Current Ratio is greater than Heart Test Laboratories, Inc. (4.49), greater than ReShape Lifesciences Inc. (1.90), greater than Inspira Technologies Oxy B.H.N. Ltd. (2.61), greater than OpGen, Inc. (0.05), greater than Bone Biologics Corporation (11.22), greater than Nuwellis, Inc. (1.20), greater than Tivic Health Systems, Inc. (7.89), greater than Talis Biomedical Corporation (7.76), greater than NanoVibronix, Inc. (2.11), greater than Bluejay Diagnostics, Inc. (4.38), greater than Vivos Therapeutics, Inc. (1.18), greater than ThermoGenesis Holdings, Inc. (0.52), greater than Sintx Technologies, Inc. (1.94), greater than Ra Medical Systems, Inc. (2.84),

Build a custom stock screener for NeuroMetrix, Inc. (NURO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroMetrix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroMetrix, Inc. (NURO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroMetrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.